If your doctor just brought up Wegovy, or you have been researching it on your own after seeing it everywhere, you probably have a long list of questions. What does it actually do? How does the dose schedule work? What side effects are you really in for? And is it even the right fit for your situation?
This guide walks through Wegovy from the ground up, using current, medically sourced information, so you can walk into your next appointment informed instead of overwhelmed.
This article is for general education and is not a substitute for medical advice. Always talk to your doctor before starting, adjusting, or stopping Wegovy.
Key Takeaways
- Wegovy is a brand name for semaglutide, the same active ingredient found in Ozempic, though the two are approved for different uses and dosed differently.
- Wegovy is FDA approved for chronic weight management and, in adults with known heart disease and obesity or overweight, to reduce the risk of major cardiovascular events.
- It is available as a once weekly injection and, since December 2025, as a once daily pill.
- Dosing starts low and increases gradually, typically reaching the standard maintenance dose of 2.4 mg around week 17.
- A higher dose option called Wegovy HD, 7.2 mg, was approved in March 2026 for patients who need additional support.
- The most common side effects are gastrointestinal and tend to be strongest right after each dose increase.
- Talk to your doctor about your full health history, including any personal or family history of certain thyroid cancers, before starting.
What Is Wegovy?
Wegovy contains semaglutide, a lab made version of a natural gut hormone called GLP1, short for glucagon like peptide 1. It works by slowing digestion, increasing feelings of fullness, and reducing hunger signals in the brain. Wegovy and Ozempic contain the exact same active ingredient, but they are not interchangeable. Ozempic is approved for type 2 diabetes, while Wegovy carries a separate FDA approval specifically for chronic weight management, and is dosed differently as a result.
Wegovy injection and Wegovy tablets are prescription medicines used with a reduced calorie diet and increased physical activity to help adults with obesity, or some adults with excess weight who also have weight related medical problems, lose weight and keep it off, as well as to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease who have obesity or overweight (Wegovy prescribing information). Wegovy injection also carries a more recent approval for treating a serious liver condition called MASH.
Injection Versus Pill
For years, Wegovy was only available as a once weekly subcutaneous injection, self administered using a prefilled pen. In December 2025, the FDA approved a once daily oral tablet version. The tablet is taken once daily in the morning with water and should be swallowed whole, never split, crushed, chewed, or dissolved (Drugs.com).
Both versions work through the same active ingredient and mechanism, but they are titrated differently, so your dose schedule will look different depending on which form your doctor prescribes.
The Wegovy Dosing Schedule
Like other GLP1 medications, Wegovy starts at a low dose and increases gradually. This slow approach exists specifically to reduce gastrointestinal side effects as your body adjusts.
For the injection, the standard schedule starts at 0.25 mg once weekly, then increases roughly every four weeks, working up toward a maintenance dose of 1.7 mg or 2.4 mg weekly. Most patients reach the standard 2.4 mg maintenance dose around week 17 (GoodRx). In March 2026, the FDA approved an additional higher maintenance option called Wegovy HD, at 7.2 mg weekly, for patients whose clinician confirms they need further weight reduction beyond the standard dose, and which can only be reached after at least four weeks at 2.4 mg (Heally).
For the oral tablet, dosing starts at 1.5 mg daily and increases roughly every 30 days, working up to a maximum of 25 mg daily (GoodRx).
Your doctor may adjust this pace based on how you tolerate each step, and reaching the highest available dose is not required for everyone. Some people do well and stay on a lower maintenance dose long term.
What to Expect in the First Weeks
The first few weeks at the starting dose tend to be the mildest, since the dose itself is low. As you move up through each increase, it is common to notice a return or worsening of digestive symptoms for several days before things settle again. This pattern tends to repeat at each new dose level, including if a dose is restarted after a gap, which is part of why the label specifically recommends following the escalation schedule again after any extended pause, rather than jumping back to a previous higher dose.
Appetite reduction is often one of the earliest noticeable effects, sometimes before much change shows up on the scale. Many people also report needing to be more deliberate about portion sizes, since it becomes easier to feel full on less food than before.
Common Side Effects
Wegovy’s most frequently reported side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, stomach pain, and heartburn. These tend to be more noticeable at higher doses, which is exactly why the dose is increased slowly over several months rather than all at once (GoodRx). Headache, fatigue, and dizziness have also been reported.
Some people notice hair shedding during a period of rapid weight loss. Current evidence does not point to Wegovy directly causing hair loss. Instead, this is more likely related to the stress rapid weight change can place on the body, a temporary condition called telogen effluvium that typically resolves over time (Drugs.com).
Talk to your doctor about strategies for managing early side effects, such as eating smaller meals, limiting high fat foods, and stopping before you feel overly full.
Serious Risks to Understand
Wegovy carries a boxed warning, the FDA’s most serious type of warning, regarding thyroid C cell tumors. In animal studies, semaglutide caused a dose dependent increase in thyroid C cell tumors, and it is not known whether this risk applies to humans, since the relevance of the rodent findings has not been determined (FDA prescribing information). Wegovy is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Other serious risks include pancreatitis, gallbladder problems, kidney injury often related to dehydration, and rare but serious allergic reactions including anaphylaxis and angioedema. Wegovy also should not be combined with other semaglutide containing products or other GLP1 receptor agonist medicines (Wegovy.com).
Talk to your doctor immediately if you notice a lump or swelling in your neck, hoarseness, trouble swallowing, shortness of breath, severe stomach pain, signs of a serious allergic reaction, or symptoms of very low blood sugar.
Who Wegovy Is Approved For
Wegovy is approved for adults with obesity, or adults with overweight who also have at least one weight related medical condition, when used alongside a reduced calorie diet and increased physical activity. It is separately approved to reduce the risk of major cardiovascular events in adults who have known heart disease along with obesity or overweight. Safety and effectiveness have not been established for reducing cardiovascular risk in people under 18, or for weight loss in children under 12 (Wegovy.com).
Whether Wegovy is right for you depends on your full medical history, current medications, and health goals, which is why a real conversation with your doctor matters more than any online checklist.
What Happens If You Stop
Wegovy’s effects on appetite and fullness depend on the medication remaining active in your body. Many people experience some return of appetite and gradual weight regain after stopping, similar to patterns seen with other GLP1 medications. This does not mean Wegovy has to be used forever for everyone, but it is worth discussing a long term plan with your doctor from the start, rather than treating it as a short term fix.
Cost and Insurance Coverage
Without insurance coverage, GoodRx pricing shows Wegovy running around $349 per month for the injection and $299 per month for the pill after any introductory pricing, though actual costs vary by pharmacy and location (GoodRx). List prices from the manufacturer can run higher.
Insurance coverage for Wegovy varies significantly depending on your plan and whether it covers obesity treatment specifically, since coverage rules for weight loss medications are often handled differently than coverage for diabetes drugs. Manufacturer savings programs can sometimes lower the out of pocket cost for people with qualifying commercial insurance, so it is worth asking your doctor’s office or pharmacist what is currently available.
Frequently Asked Questions
1. What is the difference between Wegovy and Ozempic?
Both contain semaglutide, but Wegovy is approved for chronic weight management and certain cardiovascular risk reduction, while Ozempic is approved for type 2 diabetes. They are dosed differently and are not interchangeable.
2. How long does it take to reach the full Wegovy dose?
Most patients reach the standard 2.4 mg injection maintenance dose around week 17, following a gradual increase roughly every four weeks.
3. Is the Wegovy pill as effective as the injection?
Both forms use the same active ingredient and are titrated to reach an effective maintenance dose, though they are dosed differently and your doctor can help determine which form fits your situation.
4. What is Wegovy HD?
Wegovy HD is a higher, 7.2 mg maintenance dose approved by the FDA in March 2026 for patients who need additional weight reduction beyond the standard 2.4 mg dose, available only after tolerating the standard dose first.
5. Does Wegovy cause hair loss?
There is no direct evidence linking Wegovy itself to hair loss. Temporary hair shedding some people notice is more likely related to the physical stress of rapid weight loss.
6. Can Wegovy be used with other GLP1 medications?
No. Wegovy should not be used together with other semaglutide containing products or other GLP1 receptor agonist medicines.
7. What happens if I miss a dose?
Guidance depends on how many days have passed since your missed dose, and how long you have gone without a dose overall. Check your medication guide or contact your pharmacist or doctor rather than guessing.
8. Will I regain weight if I stop taking Wegovy?
Many people experience some appetite return and gradual weight regain after stopping, since the medication’s effects depend on it remaining active in the body. A long term plan with your doctor is worth discussing early.
9. Is Wegovy safe for people without diabetes?
Yes, Wegovy is approved specifically for chronic weight management in adults with obesity or overweight, independent of diabetes status.
10. How much does Wegovy cost without insurance?
Pricing varies, but online pharmacy pricing has shown figures around $349 per month for the injection and $299 per month for the pill, not including any manufacturer savings programs that may apply.
